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Summary
BACKGROUND: Infants born very preterm are at higher
risk of long-term neurodevelopmental problems than chil-
dren born at term. Although there are increasing numbers
of reports on outcomes from international cohorts of pre-
mature infants, a Swiss national report on infants after 2
years of age is lacking.
AIMS OF THE STUDY: To describe neurodevelopmental
outcomes at early school age of preterm children born in
Switzerland with a special focus on the cognitive abilities.
METHODS: This prospective national cohort study includ-
ed children born alive before 30 weeks of gestation in
2006. At 5 years of age, children underwent a neurological
examination and intelligence testing with the Kaufman As-
sessment Battery for Children first edition (K-ABC). We
assessed the mental processing composite score (MPC)
and its subscales to explore specific cognitive deficits. The
primary outcome was cognitive impairment (MPC score
<−1 standard deviation from the normative mean), motor
impairment (cerebral palsy), or sensory impairment (any
visual or hearing deficiency). The need for early interven-
tion or therapies and the association of perinatal factors
with cognitive impairment were secondary and tertiary out-
comes. Logistic regression models were used to analyse
associations between neonatal factors and cognitive out-
come.
RESULTS: Of 289 survivors, 235 were assessed. Of the
199 children with results obtained from the K-ABC, 42
(21%) showed cognitive impairment and 80 (40%) showed
impairment in short-term memory. Cerebral palsy was di-
agnosed in 14 (6%), and visual and auditory impairment
in 36 (15%) and 12 (5%) children, respectively; 63 (27%)
needed early intervention or therapies. Cognitive impair-
ment was associated with low socioeconomic status, but
not with gestational age, small birthweight for gestational
age, bronchodysplasia, or significant brain injury. A total of
146 children (63%) survived without any impairment.
CONCLUSION: This is the first study to report neurode-
velopmental outcomes at early school age in a Swiss co-
hort. The majority had favourable outcomes, but 21% of
children demonstrated cognitive impairment, which was
most pronounced in short-term memory. Our findings were
similar to those of international cohorts and indicate that
preterm children born before 300/7 gestational weeks, es-
pecially those living in unfavourable social environments,
are at an increased risk of cognitive impairment and need
close monitoring beyond early school age.
Trial registration no: KEK-ZH-Nr.2014-0552
Keywords: Very preterm infants, neurodevelopmental
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Introduction
Progress in obstetric management and neonatal intensive
care has improved the survival of very preterm (VP) (ges-
tational age <320/7 weeks), and especially of extremely
preterm (EP) (gestational age <280/7 weeks) infants [1].
Recent long-term follow-up studies do not report a reduc-
tion in severe morbidity in this vulnerable population [2].
ABBREVIATIONS:
VP very preterm
EP extremely preterm
GW gestational weeks
MPC Mental Processing Composite
K-ABC Kaufman Assessment Battery for Children first edition
GMFCS Gross Motor Classification System
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Cognitive, language and emotional or behavioural difficul-
ties are found in around 30%, cerebral palsy in 10–15%
[3] and visual or hearing impairments in 3–5% [4] of pre-
schoolers born before 340/7 gestational weeks (GW). A
substantial proportion (15–20%) of children born VP re-
quire physical and occupational therapy, speech and lan-
guage therapy, early intervention, psychological support
[5] or remedial assistance in school, which represents a sig-
nificant economic burden for society and families.
In Switzerland, VP children represent 1% of the annual
births (https://www.bfs.admin.ch/). A previous Swiss na-
tional cohort study demonstrated that a third of children
born EP suffer from moderate to severe neurodevelopmen-
tal impairment at a corrected age of 2 years [6]. Studies
have shown the limited validity of early developmental as-
sessment (between 1 and 3 years of age) in predicting cog-
nitive deficits at school age [7]. However, a recent study
reported a good correlation between the intelligent quotient
in adulthood (26 years) and the one at 4 years in VP chil-
dren with persistent cognitive impairment and at 6 years of
age in VP children without cognitive impairment [8]. As-
sessments of recent cohorts of VP children at early school
age are scarce. However, a recent Dutch study showed that
50–75% of children born at <300/7 GW still have motor
and/or cognitive impairment between 5 and 6 years of age
[9]. Therefore, it seems important to increase our under-
standing of neurodevelopmental outcomes at early school
age to improve prognostication. The goal is to provide ear-
ly therapeutic strategies to impact positively later cognitive
development and social integration.
The primary aim of our exploratory study was to describe
neurodevelopmental outcome at early school age in a
Swiss national cohort of children born before 300/7 GW
in 2006, with a specific focus on cognitive outcomes. The
second aim was to assess the number of children who re-
ceived early intervention or therapies. The third aim was
to investigate which perinatal factors were associated with
impaired cognitive outcome.
Methods
Study population
This study is a prospective multicentre population-based
cohort study. Children born alive at <300/7 GW in Switzer-
land between January 1 and December 31 2006 and regis-
tered in the Swiss Neonatal Network and Follow-up Group
were included. Children with congenital malformations af-
fecting neurodevelopment (complex congenital heart dis-
eases, hiatal hernia, polymicrogyria, midline malformation
syndromes, myelomeningocele) were excluded, as were
children from centres that did not routinely perform stan-
dardised cognitive assessment at 5 years of age. Monitored
children were examined in the participating Swiss develop-
ment centres by developmental paediatricians, paediatric
neurologists and developmental psychologists.
Ethics
Parents were informed during the neonatal stay that all
data concerning their VP infants would be collected and
registered in the national database. Data collection and
evaluation were approved by the institutional ethical re-
view board (KEK-ZH-Nr20140552) and the Swiss Federal
Commission for Privacy Protection in Medical Research.
Data collection and definition of neonatal variables
Demographic, perinatal and neurodevelopmental outcome
data, as well as the use of early intervention or therapies
(physical therapy, occupational therapy, speech therapy,
psychomotor therapy, psychological therapy) at early
school age, were routinely recorded online with a secure
interface protecting confidentiality and applying complete-
ness and plausibility checks. Gestational age was based on
the best estimate from early ultrasound or last menstrual
period. Birth weight z-score calculations, patent ductus
arteriosus, neonatal sepsis, bronchopulmonary dysplasia,
necrotising enterocolitis [10], major brain injury (such as
intraventricular haemorrhage grade 3 or 4 and/or cystic
leukomalacia) and retinopathy of prematurity were defined
as previously published for this cohort. Socioeconomic sta-
tus (SES) was estimated from maternal education and pa-
ternal occupation using a validated 12-point score (range
2–12) [11], 2 being the highest socioeconomic level.
Neurodevelopmental assessment
Cognition was assessed around the children’s fifth birthday
using the German, French and Italian versions of the Kauf-
man Assessment Battery for Children first edition (K-
ABC) [12], validated in the general population and in VP
children. The Mental Processing Composite (MPC) scale,
considered equivalent to an intelligence quotient, is a gen-
eral measure of cognitive ability and is derived from a
combination of the two subscales of sequential and si-
multaneous processing. The sequential processing subscale
primarily measures short-term memory with two subtests
targeting auditory short-term memory (word order and
number recall) and one subtest testing visual short-term
memory (hand movements). The simultaneous processing
subscale examines the abilities to solve problems related
to visuospatial information: matrix analogies (logical rea-
soning), triangles (visuospatial processing), spatial memo-
ry and gestalt closure (visual perception).
Each scale and subscale is standardised to a mean (stan-
dard deviation [SD]) of 100 (15), and each subtest to a
mean of 10 (3). If the MPC score was below 40 (the lowest
score on the K-ABC), the child was assigned a score of 39.
Mild cognitive impairment was defined as MPC score <−1;
≥−2 SD and moderate to severe cognitive impairment <−2
SD below the normative mean.
Each child underwent a standardised neurological exami-
nation. Cerebral palsy was defined according to the defi-
nition published by Rosenbaum et al. [13] and classified
according to the guidelines of the Surveillance Group of
Cerebral Palsy in Europe [14]. Gross motor function was
classified according to the Gross Motor Classification Sys-
tem (GMFCS) [15]. We further categorised participants
with cerebral palsy into community walkers (GMFCS 1–2)
and non-community walkers and wheelchair-dependent
(GMFCS 3–5).
Major visual impairment was defined as blindness, and
minor visual impairment as the presence of squint or re-
fractive errors. Major hearing impairment was defined as
hearing loss not corrected by hearing aids, and minor im-
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pairment as hearing loss corrected with aids (40–90 dB
hearing level).
Statistical analysis
Statistical analysis was performed with STATA 14 soft-
ware and R (3.4.2). All demographic and developmental
data are described as frequencies and percentages for cat-
egorical data and as means and standard deviations or me-
dians and ranges, as appropriate, for continuous data. For
categorical data, differences were assessed using the chi-
squared test or Fisher’s exact test, as appropriate. For con-
tinuous data, the Student’s t-test or the Mann-Whitney U-
test were used, as appropriate. Comparisons are presented
as odds ratios [16] or mean differences, with 95% confi-
dence intervals (CIs) and p-values. A two-tailed p-value
<0.05 was considered significant for all analyses. No ad-
justment was made for multiple comparisons.
Univariable logistic regressions were conducted to define
individual associations between neonatal factors known
from the literature [6, 16–18] to influence neurodevelop-
mental outcome (gestational age, gender, birthweight z-
score, antenatal corticosteroids, patent ductus areteriosus,
necrotising enterocolitis, bronchopulmonary dysplasia,
major brain injury, socioeconomic status) and cognitive
impairment defined as MPC score <−1SD. Only variables
with a p-value below 0.2 in the univariable setting were in-
cluded in the final multivariable model; the other variables
were excluded as they had no influence on the model. Re-
sults are reported as odds ratios with 95% CIs.
Results
Participants
In 2006, 73,371 infants were born alive in Switzerland. Of
these, 405 were born before 300/7 GW. A flow chart of
study recruitment and follow-up is shown in figure 1. We
excluded two children because of a trisomy 21 and val-
proic acid embryopathy and 22 children because they were
born in three centres that did not perform standardised cog-
nitive assessment at 5 years of age. The mortality rate was
24% (92/381), with 36 infants dying in the delivery room,
55 in neonatal intensive care, and 1 in the first year of
life. All infants born at 23 completed GW (n = 19) died in
the delivery room. The proportion of infants surviving in-
creased with gestational age from 27% at 240/7–246/7 weeks
to 93% at 290/7–296/7 weeks (see supplementary table S1 in
appendix 1).
At early school age, 289 surviving children were invited to
be assessed in the Swiss 5-year follow-up programme, of
whom 235 (81%) were examined; in total, 123 were born
between 280/7 GW and <296/7 GW and 112 were born <280/
7 GW. Reasons for non-participation included moving (n =
9, 17%), parental refusal (n = 11, 20%), age of assessment
outside the targeted range of 4.5 and 6.5 years (n = 7, 13%)
and loss to follow-up (n = 27, 50%). Baseline characteris-
tics were similar between monitored (n = 235) and lost to
follow-up children (n = 54; table 1) and only statistically
different for twin births between monitored (n = 235) and
excluded children (n = 22; table S2 in appendix 1).
Table 1: Comparison of baseline and neonatal characteristics of children with and without a follow-up at early school age.
Children with follow-up
(n = 235)
n (%) or
median (IQR)
Children without follow-up
(n = 54)
n (%) or
median (IQR)
p-value
Antenatal steroids (completed) 209 (89%) 47 (87%) 0.69
Caesarean delivery 182 (77%) 40 (74%) 0.09
Singleton 163 (69.3%) 40 (74%) 0.60
Inborn 218 (92.8%) 50 (92.6%) 1.00
Male gender 129 (55%) 25 (46%) 0.23
Gestational age (weeks) 28.1 (26.7–29) 28.3 (26.6–29) 0.46
Birthweight z-score −0.04 (−0.65 – +0.53) 0.01 (−0.64 – +0.4) 0.90
Umbilical artery pH 7.32 (7.27–7.35) 7.31 (7.25–7.34) 0.22
PDA
Surgical ligation
90 (38%)
9 (4%)
18 (33%)
4 (7%)
0.50
0.27
Bronchopulmonary dysplasia 9 (4%) 2 (3.5%) 0.99
Necrotising enterocolitis 10 (4.3%) 0 0.99
Proven neonatal sepsis 46 (19.6%) 7 (13%) 0.30
Major brain lesions 22 (9.3%) 2 (3.7%) 0.30
ROP stage 3 or higher 5 (2%) 2 (3.5%) 0.45
Length of hospital stay (in days) 76 (59–73) 71.5 (55.5–90) 0.23
SES score at birth 6 (4–8) 6 (4–8) 0.20
IQR = interquantile range; PDA = patent ductus arteriosus; ROP = retinopathy of prematurity; SES = socioeconomic status (score range 2–12; score 2 is the highest socioe-
conomic level, 12 the lowest socioeconomic level) p-values are from the Mann-Whitney U-test for continuous variables, and Fisher exact or chi-squared tests for categorical or
binary outcomes. Proven neonatal sepsis is grouped as early- and late-onset sepsis. Major brain lesions included cystic leukomalacia and intraventricular haemorrhage grade 3
and 4.
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Cognitive outcome
Of the 235 children seen for the 5-year follow-up, 202
were assessed with the K-ABC at a median age of 5.7
years (interquartile range [IQR] 5.5–6.0), of whom 199
Figure 1: Study recruitment and follow-up.GW = gestational
weeks; FU = follow up; NICU = neonatal intensive care unit; K-
ABC = Kaufman Assessment Battery for Children, first edition;
SON-R = Snijders-Oomen non-verbal intelligence tests; WPPSI-III
= Wechsler Preschool and Primary Scale of Intelligence, third edi-
tion; WISC-IV = Wechsler Intelligence Scale for Children, fourth
edition.
had available scores (fig. 1). Cognitive outcomes are pre-
sented in table 2. The median (IQR) MPC score was 92
(86–101); 17.5% of the children showed mild cognitive
impairment (MPC <−1; ≥−2 SD) and 3.5% moderate to
severe cognitive impairment (MPC <−2 SD). The propor-
tion infants with of cognitive impairment was higher in
boys (26/107) than in girls (9/92, p = 0.009). Impairment
(<−1 SD) in cognitive subdomains was found in 84 (42%)
and 80 children (40%) in subtests assessing verbal short-
term memory (word order and number recall, respective-
ly), 60 children (31%) in visual short-term memory (hand
movements), 61 children (31%) in logical reasoning (ma-
trix analogies), 53 children (27%) in visuospatial process-
ing (triangles), 45 children (23%) in spatial memory, and
23 children (12%) in visual perception (gestalt closure).
Table S1 shows the cognitive outcomes by week of gesta-
tional age.
Motor and sensory outcome
Motor and sensory outcomes at a median age of 5.7 years
are summarised in table 3. Cerebral palsy was present in 14
children (6%). The cerebral palsy rate was not different be-
tween children born <280/7 GW and children born between
280/7 and 296/7 GW. Seventy percent of children who de-
Table 2: Overview of cognitive outcomes with subtest scaled scores by sex grouped by both scales composing the Mental Processing Composite.
Whole cohort
n = 199
Boys
n = 107
Girls
n = 92
Boys versus Girls
Mean (SD) Mean (SD) Mean (SD) Mean difference (95% CI)
MPC score 92.5 (12.4) 91.7 (1.3) 93.5 (1.2) −1.8 (−5.3 – +1.7)
Sequential process-
ing
Overall 91.9 (14) 91.5 (14.7) 92.4 (14) −0.9 (−4.9 – +3.2)
Word order 7.4 (2.8) 7.2 (2.8) 7.7 (2.9) −0.5 (−1.3 – +0.3)
Number recall 7.2 (2.3) 7.2 (2.4) 7.2 (2.4) 0.1 (−0.6 – +0.8)
Hand movements 8 (2.7) 7.9 (2.9) 8.1 (2.6) −0.17 (−0.95 – +0.6)
Simultaneous pro-
cessing
Overall 93.8 (15) 92.6 (15.4) 95.1 (14.6) −2.5 (−6.7 – +1.7)
Matrix analogies 7.5 (2.7) 7.4 (2.9) 7.7 (2.6) −0.3 (−1 – +0.5)
Triangles 8.4 (3.2) 8.2 (3.4) 8.6 (3) −0.3 (−1.25 – +0.6)
Spatial memory 8.5 (3.2) 8.4 (3.2) 8.5 (3.3) −0.6 (−1 – +1)
Gestalt closure 10.6 (3.2) 10.5 (3.4) 10.8 (3) −0.4 (−1.3 – +0.55)
n (%) n (%) n (%) Odds ratio
(95% CI)
MPC score <−1 SD 42/199 (21) 29/107 (27) 13/92 (14) 2.2 (1.1–4.5)
<−2 SD 7/199 (3.5) 3/107 (2.8) 4/92 (4.3) 0.6 (0.14–2.85
Sequential process-
ing
Overall <−1 SD 60/199 (30.1) 34/107 (31.8) 26/92 (28.3) 1.18 (0.6–2.2)
<−2 SD 12 /199 (6) 8/107 (7.5) 4/92 (4.3) 1.77 (0.5–6.1)
Word order <−1 SD 85/199 (42.7) 56/107 (52.3) 39/92 (42.4) 1.4 (0.8–2.4)
<−2 SD 11/199 (5.5) 7/107 (6.5) 4/92 (4.3) 1.5 (0.4–5.4)
Number recall <−1 SD 80/199 (40.2) 41/107 (38.3) 39/92 (42.4) 0.8 (0.5–1.5)
<−2 SD 9/199 (4.5) 5/107 (4.7) 4/92 (4.3) 1.1 (0.3–4.1)
Hand movements <−1 SD 60/199 (30.2) 37/107 (34.6) 23/92 (25%) 1.5 (0.8–2.9)
<−2 SD 8/199(4) 5/107 (4.7) 3/92 (3.2) 1.4 (0.3–6.1)
Simultaneous pro-
cessing
Overall <−1 SD 51/199 (25.6) 30/107 (30) 21/92 (22.8) 1.3 (0.7–2.5)
<−2 SD 11/199 (5.5) 5/107 (4.7) 6/92 (6.5) 0.7 (0.2–2.4)
Matrix analogies <−1 SD 61/199 (31) 37/107 (35) 24/92 (26) 1.5 (0.8–2.8)
<−2 SD 12/199 (6) 8/107 (7.5) 4/92 (4) 0.3 (0.02–2.8)
Triangles <−1 SD 53/199 (27) 30/107 (28) 23/92 (25) 1.2 (0.6–2.2)
<−2 SD 20/199 (10) 14/107 (13) 6/92 (6.5) 2.2 (0.8–5.9)
Spatial memory <−1 SD 45/199 (23) 26/107 (24) 19/92 (21) 1.3 (0.6–2.4)
<−2 SD 14/199 (7) 7/107 (6.5) 7/92 (7.6) 0.9 (0.3–2.5)
Gestalt closure <−1 SD 23/199 (12) 15/107 (14) 8/92 (9) 1.7 (0.7–4.2)
<−2 SD 4/199 (2) 2/107 (1.9) 2/92 (2) 0.85 (0.1–6.2)
CI = confidence interval; MPC = Mental Processing Composite; SD = standard deviation
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veloped cerebral palsy had brain lesions visible on a head
ultrasound scan.
Visual and hearing impairments were found in 36 (15%)
and 12 children (5.1%), respectively. Of these, one child
was blind, two were deaf and four had both visual and
hearing impairment. Visual and hearing impairments were
similar in children born <280/7 GW and children born be-
tween 280/7 and 296/7 GW (25/112 [22%] and 23/123 [8%],
respectively). Sex was not associated with the frequency of
cerebral palsy, or visual and hearing impairments.
Early intervention and therapies
Up to the 5-year follow-up, 103/235 (44%) children had
at least one intervention/therapy at some point during their
early years of life. At the 5-year follow-up, 63 children
(27%) still needed one or more services. Speech therapy
was the most frequently prescribed service (12%), fol-
lowed by occupational therapy (9%), physical therapy
(6%), early intervention (6%), psychomotor therapy
(4.5%) and psychological support (2.5%). Need for thera-
py was similar in children born <280/7 GW and those born
between the 280/7 and 296/7 GW (table 4). The median so-
cioeconomic status scores of families of children with and
without the utilisation of service(s) did not differ (medi-
an 6, IQR 6–9). Boys used more services than girls (42/
87 vs 21/104, p = 0.04). The mean MPC score in children
still under early intervention or therapy at 5-year follow-
up was 11.0 points lower than that in children who never
used services at all (95% CI: −17.5 to −4.5, p <0.001). Out
of the 63 children still under early intervention or therapy,
23 had at least one of three neurological morbidities, such
as cerebral palsy (11 children), visual impairment (14 chil-
dren, and auditory impairment (5 children).
Risk factors for cognitive impairment and need for
early intervention or therapies
Univariable analyses showed that the risk of having cogni-
tive impairment was higher for boys, children with major
brain lesions and for children living in families with low
socioeconomic status. In the multivariable model, the sin-
gle strongest predictor for cognitive impairment was a low
socioeconomic status score (adjusted OR 1.2, 95% CI
1.06–1.4; table 5).
In the multivariable model, any current use of a service at
5-year follow-up was associated with male sex (adjusted
OR 2.0, 95% CI 1.0–3.9), major brain lesions (adjusted
OR 2.7, 96% CI 1.3–5.7), and lower socioeconomic status
score (adjusted OR 2.7, 95% CI 1.3–4.9).
Discussion
This prospective national cohort study showed that the ma-
jority of children born <30 GW in Switzerland in 2006
had a favourable cognitive, motor and sensory outcome at
early school age. Although they had cognitive scores in
the lower normal range on average, a fifth of the children
demonstrated cognitive impairment and subtest analyses
showed that impairment was greatest in short-term memo-
ry. Whereas at least 40% of the children had used educa-
tional health services at some time point during the past,
only a quarter of them still attended one or more services at
the time of the 5-year follow-up assessment. Lower socioe-
conomic status was the only factor associated with cogni-
tive impairment in our study population.
Table 3: Motor and sensory impairment at early school age by gestational age.
All children
240/7–296/7 GW
n = 235
Extremely preterm children
240/7–276/7 GW
n = 112
Very preterm children
280/7–296/7 GW
n = 123
n (%) n (%) 95% CI n (%) 95% CI
Cerebral palsy All 14/235 (6) 6/112 (5.4) 2.4–11.5 8/123 (6.5) 3.3–12.5
GMFCS level 1–2* 7/235 (3) 4/112 (3.6) 1.3–6.1 3/123 (2.4) 0.7–7.4
GMFCS level 3–5 6/235 (2.5) 2/112 (1.8) 0.4–6.9 4/123 (3.3) 1.2–8.4
Visual impairment Minor 35/235 (14.9) 18/112 (16.1) 10.3–24.2 17/123 (13.8) 8.7–21.2
Major 1/235 (0.4) 1/112 (0.9) n.a. 0 n.a.
Hearing impairment Minor 10/235 (4.3) 5/112 (4.5) 1.8–10.4 5/123 (3.9) 1.9–9.2
Major 2/235 (0.9) 1/112 (0.9) n.a. 1/123(0.8) n.a.
GMFCS = Gross motor function classification system. GMFCS level 1–2: mildest form, child can walk independently; GMFCS level 3–5: child uses device or requires physical
assistance to walk. * GMFCS level for one child is unknown. For all comparisons between extremely preterm children and very preterm children (p >0.05)
Table 4: Early intervention and therapies at early school age by gestational age group.
All cohort
240/7–290/7
n = 235
Children born
240/7–76/7
n = 112
Children born
280/7–296/7
n = 123
p-value
Any therapies/early intervention* 63/235 (27%) 33/112 (29.5%) 30/123 (24.4%)
One therapy 13/235 (5.5%) 7/112 (6.3%) 6/123 (4.9%) 0.4
Multiple therapies 50/235 (21.3%) 26/112 (23.2%) 24/123 (19.5%) 0.84
Physiotherapy 14/235 (6%) 8/112 (7.1%) 6/123 (4.9%) 0.58
Occupational therapy 21/235 (8.9%) 11/112 (9.8%) 10/123 (8.1%) 0.65
Speech therapy 29/235 (12.3%) 15/112 (13.4%) 14/123 (11.4%) 0.64
Early intervention* 14/235 (6%) 7/112 (6.3%) 7/123 (5.7%) 1
Psychomotor therapy 10/235 (4.3%) 6/112 (5.4%) 4/123 (3.3%) 0.52
Child psychology or psychiatry 6/235 (2.6%) 2/112 (1.8%) 4/123 (3.3%) 0.7
Values are numbers (percentage); p-values are from Fisher exact test for ratios * Early intervention is a weekly stimulation at home by a therapist with the aim to promote the
cognitive development and to support the parent in their educative role.
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In this study, neonatal mortality depended strongly on ges-
tational age and was slightly lower for EP infants than re-
ported in other international cohorts [2, 19].
Compared to the K-ABC norms, our study population
showed cognitive scores in the lower normal range. These
results are not surprising, as group means of cognitive
performance in VP children have been shown to be one
half to two thirds of a standard deviation below the group
means of term -born children [20]. Our results are in line
with a recent meta-analysis [21] that included 44 case-con-
trol studies using different IQ measures in 4- to 17-year-
old children born VP, in the period from 1980 to 2009.
The meta-analysis showed a 12-point difference in IQ (0.8
SD) for preterm children in comparison to their term-born
peers. This corresponds to a mean performance within
the normal range, but group means do not necessarily re-
flect the heterogeneity within the group. In our study, the
subscore analysis of cognitive outcomes revealed that a
large proportion of the children born before 300/7 GW
(40%) showed low performance in two subtests of verbal
short-term memory and visual short-term memory (31%).
Deficits in all memory domains have been reported in VP
children, with VP children being 2–3 times more likely to
have memory impairments than term-born control children
[22]. Considerable difficulties in visual short-term mem-
ory, visuospatial and visual processing, logical reasoning
and spatial memory have been reported in school-age VP
children [23]. Our results are in line with the current liter-
ature on cognitive difficulties in VP children and highlight
the need for early detection and adequate support.
The prevalence of cerebral palsy in our population (6%)
was comparable to that described in literature rendered for
the same gestational age and period of time [24]. Com-
parison of our rates of visual and hearing impairment with
those of other cohorts is difficult, because different defini-
tions were used. However, our rate of major visual impair-
ment (0.4%) was similar to the blindness rate at 5 years of
age reported in the EPIPAGE Cohort Study (0.7%) in chil-
dren born 240/7–296/7 GW [25].
As in previous studies, we found that the socioeconomic
level of the family was associated with impaired cognitive
outcome during early schooling. A recent systematic re-
view based on 12 studies explored the predictive factors of
cognitive development at the age of 5–13 years in children
born before 330/7 GW and identified the level of parental
education as a prognostic factor for cognitive outcome,
whereas younger gestational age and parental income/oc-
cupation had little prognostic value [26].
The current study found the proportion of children under
any form of intervention or therapy at early school age
(27%) slightly lower than that reported in a Dutch study
(40% of 64 children born <300/7 GW) [27] and in the EPI-
PAGE cohort (36% of 922 children born <310/7 GW). In
our study, only major brain lesions and lower socioeco-
nomic status score were associated with use of therapies at
a median age of 5.7 years. Out of the children undergoing
one or several interventions or therapies at that age, only
36.5% had neurological morbidities, such as cerebral pal-
sy, visual impairment or auditory impairment. Although a
few randomised controlled studies have assessed the effi-
ciency of early interventions over the first year of life in in-
fants without neurosensory impairments [28], the need for
therapies can be considered a good indirect indicator for
the existence of developmental difficulties in children born
VP and should encourage further diagnostic investigations
to provide them with more specific educational support.
This study has several clinical implications. VP children,
including those with no apparent morbidities, should have
neuropsychological follow-up in order to monitor cogni-
tive problems. Preterm children living in unfavourable so-
cial circumstances are particularly vulnerable. The combi-
nation of VP birth and low parental socioeconomic status
creates a situation in which children are exposed to a com-
bination of biological and environmental risk factors that
may impact their cognitive development.
A first limitation of our study was the sample size (n =
235) eligible for the 5-year follow-up assessment, which
corresponds to a rate of 80%. Sackett et al. suggested that a
dropout rate of more than 20% poses a serious threat to va-
lidity [29]. However, neonatal baseline characteristics and
social background did not differ between participants and
nonparticipants, meaning that the sample examined might
be considered as representative for the whole cohort. A
second limitation was the exclusion of 22 children with-
out access to national 5-year follow-up. Monitored chil-
dren might have been at a higher risk of poor cognitive
outcomes than children born in a centre where follow-up
was not performed routinely. Therefore, there is a possi-
ble slight underestimation of cognitive outcomes in our co-
hort. A third limitation is the absence of a control group
of children born at term. For this reason, we relied on test
norms as a baseline in the estimate of the level of cogni-
Table 5: Factors associated with an impaired cognitive outcome defined as a MPC score <−1SD at early school age.
Univariable Multivariable
OR (95% CI) p-value OR (95% CI) p-value
Born extremely preterm*
(240/7–276/7 GW)
0.9 (0.7–1.1) 0.30
Birthweight z-score 1.4 (0.9–2.2) 0.11 0.64 (0.4-1) 0.051
Multiple gestation 1.9 (0.9–3.8) 0.09 0.57 (0.05-4.22) 0.67
Male gender 2.3 (1.1–4.7) 0.03 2.1 (0.95-6.6) 0.06
Patent ductus arteriosus 0.76 (0.4–1.5) 0.40
Antenatal corticosteroids (completed) 1.04 (0.4–3) 0.90
Necrotising enterocolitis 0.46 (0.2–1.3) 0.10 0.2 (0.02–1.8) 0.15
Neonatal sepsis 1.5 (0.7–3.3) 0.30
Bronchopulmonary dysplasia 1.5 (0.3–8.1) 0.60
Major brain lesions 2.9 (1–8.2) 0.04 2.3 (0.7–7.7) 0.15
Socioeconomic status† 3.9 (1.4–10.6) 0.007 1.2 (1.06-1.4) 0.009
MPC = Mental Processing Composite; CI = confidence interval; OR = odds ratio * Compared with infants born very preterm (280/7–296/7) † Analysed as a continuous variable
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tive functioning of the study children. As the sociodemo-
graphic characteristics of the VP children assessed in this
study are likely to differ from the standardisation sample,
we might have underestimated the rates of impairment in
our Swiss cohort. Fourth, while we report cognitive find-
ings at the subtest level, it is important to note that the sub-
tests are part of the K-ABC test battery, which is designed
to measure general cognitive ability. These measures can
provide additional information about the nature of cogni-
tive difficulties, but specialised neuropsychological mea-
sures are necessary for detecting specific cognitive weak-
ness.
Conclusion
This is the first study to provide an overview of the cog-
nitive and neurological outcomes at an early school age
for children born <300/7 GW in Switzerland. Compared to
larger, well-known international cohort studies, our results
revealed similar cognitive, motor and sensory outcomes.
We found that one fifth of children showed cognitive im-
pairments, and two fifths showed poor short-term mem-
ory. VP children often need one or several interventions
or therapies, even when they are not diagnosed with se-
vere neurodevelopmental impairment. Our findings high-
light the need to offer long-term neuropsychological fol-
low up in children born <300/7 GW, in particular children
from socially disadvantaged families.
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Appendix 1 Supplementary tables
Table S1: Mortality and cognitive outcome at early school age according to gestational age.
Death Median MPC (IQR) MPC 85
(−1SD)
MPC 84-70
(<−1; −2SD)
MPC<70
(<−2SD)
Whole cohort 92/381 (24.1%) 92 (86–101) 157/199 (79%) 35/199 (18.5%) 7/199 (3.5%)
Gestational age
(weeks)
EP 82/217 (37.8%) 93 (87–101) 78/95 (82,1%) 15/95 (15.8%) 2/95 (2.1%)
VP 10/164 (6.1%) 92 (85–101) 79/104 (76%) 20/104 (19.2%) 5/104 (4.8%)
p-value < 0.001 0.27 0.30 0.50 0.45
Completed weeks 23 19/19 (100%)
24 24/33 (73%) 89 (78–99) 5/7 (71%) 1/7 (14%) 1/7 (14%))
25 13/38 (34%) 96 (91–107) 19/21 (90%) 2/21 (10%) -
26 17/58 (29%) 92 (87–101) 26/30 (87%) 4/30 (13%) -
27 9/69 (13%) 93.5 (86–101) 42/51 (82%) 8/51 (16%) 1/51 (2%)
28 4/77 (5%) 92 (84–101) 46/59 (78%) 11/59 (19%) 2/59 (3%)
29 6/87 (6.9%) 91 (85–101) 52/64 (81%) 9/64 (14%) 3/64 (5%)
EP = extremely preterm infants (born between 240/7 and 276/7 gestational weeks);MPC = Mental Processing Composite; IQR = interquantile range; SD = standard deviation; VP =
very preterm infants (born between 280/7 and 296/7 gestational weeks) p-values are from by t-tests for continuous variables, from Fisher exact or chi-squared tests for categorical
or binary outcomes.
Table S2: Comparison of baseline and neonatal characteristics of children with a follow-up at early school age and children excluded due to the lack of access to the national
follow-up program at 5 years of age.
Children with follow-up
(n = 235)
n (%) or
median (IQR)
Excluded children
(n = 22)
n (%) or
median (IQR)
p-value
Antenatal steroids (completed) 209 (89%) 19 (86%) 0.72
Caesarean delivery 182 (77%) 16 (73%) 0.61
Singleton 163 (69.3%) 22 (100%) 0.001
Inborn 218 (92.8%) 22 (100%) 0.2
Male gender 129 (55%) 14 (63%) 0.5
Gestational age (weeks) 28.1 (26.7–29) 28.3 (26.6–29.1) 0.92
Birthweight z-score −0.04 (−0.65–+0.53) 0.29 (−0.32–+0.4) 0.61
Umbilical artery pH 7.32 (7.27–7.35) 7.22 (7.16–7.22) 0.96
PDA with surgical ligation 9 (4%) 0 0.99
Bronchopulmonary dysplasia 9 (4%) 0 0.99
Necrotising enterocolitis 10 (4.3%) 0 0.99
Proven neonatal sepsis 46 (19.6%) 3 (13%) 0.77
Major brain lesions 22 (9.3%) 3 (13.6%) 0.45
ROP stage 3 or higher 5 (2%) 0 0.99
Length of hospital stay (in days) 76 (59–73) 86 (65–100) 0.4
SES score at birth 6 (4–8) 6 (5–7) 0.20
IQR = interquantile range; PDA = patent ductus arteriosus; ROP = retinopathy of prematurity; SES = socioeconomic status (score range 2–12; score 2 is the highest socioeco-
nomic level, 12 the lowest socioeconomic level). p-values are from the Mann-Whitney U-test for continuous variables, and Fisher exact or chi-squared tests for categorical or
binary outcomes. Proven neonatal sepsis is cactegorised into early- and late-onset sepsis. Major brain lesions included cystic leukomalacia and intraventricular haemorrhage
grade 3 and 4.
Original article Swiss Med Wkly. 2019;149:w20084
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 9 of 9
